Alcohol metabolism and cancer risk.
Chronic alcohol consumption increases the risk for cancer of the organs and tissues of the respiratory tract and the upper digestive tract (i.e., upper aerodigestive tract), liver, colon, rectum, and breast. Various factors may contribute to the development (i.e., pathogenesis) of alcohol-associated cancer, including the actions of acetaldehyde, the first and most toxic metabolite of alcohol metabolism. The main enzymes involved in alcohol and acetaldehyde metabolism are alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), which are encoded by multiple genes. Because some of these genes exist in several variants (i.e., are polymorphic), and the enzymes encoded by certain variants may result in elevated acetaldehyde levels, the presence of these variants may predispose to certain cancers. Several mechanisms may contribute to alcohol-related cancer development. Acetaldehyde itself is a cancer-causing substance in experimental animals and reacts with DNA to form cancer-promoting compounds. In addition, highly reactive, oxygen-containing molecules that are generated during certain pathways of alcohol metabolism can damage the DNA, thus also inducing tumor development. Together with other factors related to chronic alcohol consumption, these metabolism-related factors may increase tumor risk in chronic heavy drinkers.
Seitz
Helmut K
HK
Center ofA lcohol Research, Liver Disease and Nutrition, Salem Medical Center, University ofHeidelberg, Heidelberg, Germany.
Becker
Peter
P
D000079:Acetaldehyde / Q000633:toxicity; D000426:Alcohol Dehydrogenase / Q000235:genetics* / Q000378:metabolism; D020751:Alcohol-Induced Disorders / Q000201:enzymology* / Q000235:genetics*; D000444:Aldehyde Dehydrogenase / Q000235:genetics* / Q000378:metabolism; D000483:Alleles; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000235:genetics; D004067:Digestive System Neoplasms / Q000139:chemically induced* / Q000235:genetics; D000431:Ethanol / Q000378:metabolism* / Q000633:toxicity; D020022:Genetic Predisposition to Disease; D006801:Humans; D011110:Polymorphism, Genetic; D012307:Risk Factors
D000431:Ethanol; D000426:Alcohol Dehydrogenase; D000444:Aldehyde Dehydrogenase; D000079:Acetaldehyde
Nucleic Acids Res. 2005;33(11):3513-20
15972793
Int J Cancer. 2006 Apr 15;118(8):1998-2002
16287084
Carcinogenesis. 2006 Apr;27(4):840-7
16344274
Biol Chem. 2006 Apr;387(4):349-60
16606331
Lancet Oncol. 2007 Apr;8(4):292-3
17431955
Alcohol Clin Exp Res. 2000 Jun;24(6):873-7
10888077
Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1099-105
11045794
Cancer Res. 2000 Oct 15;60(20):5635-9
11059753
Carcinogenesis. 2001 Jan;22(1):57-61
11159741
JAMA. 2001 Nov 7;286(17):2143-51
11694156
J Hepatol. 2002 Jan;36(1):47-52
11804663
Alcohol Res Health. 2001;25(4):263-70
11910703
Scand J Gastroenterol. 2002 Jun;37(6):648-55
12126241
Br J Cancer. 2002 Nov 18;87(11):1234-45
12439712
Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):419-25
12750236
Am J Epidemiol. 2004 Jan 1;159(1):1-16
14693654
Int J Cancer. 2004 Feb 10;108(4):483-7
14696110
Alcohol Alcohol. 2004 May-Jun;39(3):155-65
15082451
Ann Intern Med. 2004 Apr 20;140(8):603-13
15096331
Gut. 2004 Jun;53(6):871-6
15138216
Int J Cancer. 2004 Sep 10;111(4):480-3
15239123
Int J Oncol. 2004 Oct;25(4):1127-32
15375565
Mutat Res. 1986 May;174(1):47-51
2939344
Biochemistry. 1988 Jun 14;27(12):4284-8
3166980
Gastroenterology. 1990 Feb;98(2):406-13
2295396
Semin Liver Dis. 1993 May;13(2):126-35
8337601
Cancer Causes Control. 1994 Jan;5(1):73-82
8123780
J Natl Cancer Inst. 1995 Feb 15;87(4):265-73
7707417
Alcohol Clin Exp Res. 1996 Oct;20(7):1192-5
8904969
Alcohol Clin Exp Res. 1996 Oct;20(7):1206-10
8904972
Hum Genet. 1997 Mar;99(3):319-25
9050916
J Natl Cancer Inst. 1997 Nov 19;89(22):1698-705
9390539
Carcinogenesis. 1998 Aug;19(8):1383-7
9744533
Eur J Cancer Prev. 1999 Feb;8(1):57-62
10091044
IARC Monogr Eval Carcinog Risks Hum. 1999;71 Pt 1:1-315
10507919
Cancer Causes Control. 1999 Oct;10(5):369-77
10530606